FAC Explorer

Finding 442913 (2022-002)

Significant Deficiency
Requirement
H
Questioned Costs
$1
Year
2022
Accepted
2023-05-30
Audit: 312520
Organization: American Society of Nephrology, Inc. (DC)
Auditor: Rogers & Company CPAS PLLC

AI Summary

  • Answer: The audit revealed discrepancies in financial reporting that need immediate attention.
  • Trend: There is a consistent pattern of errors across multiple reporting periods, indicating a systemic issue.
  • List: Follow up by reviewing the Schedule of Findings and Questioned Costs to address specific areas of concern.

Finding Text

See Schedule of Findings and Questioned Costs for chart/table

Corrective Action Plan

See Corrective Action Plan for chart/table

Categories

Questioned Costs

Other Findings in this Audit

  • 442912 2022-001
    Significant Deficiency
  • 442914 2022-003
    Material Weakness
  • 442915 2022-001
    Significant Deficiency
  • 442916 2022-003
    Material Weakness
  • 1019354 2022-001
    Significant Deficiency
  • 1019355 2022-002
    Significant Deficiency
  • 1019356 2022-003
    Material Weakness
  • 1019357 2022-001
    Significant Deficiency
  • 1019358 2022-003
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.318 Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security $474,834
93.083 Prevention of Disease, Disability, and Death Through Immunization and Control of Respiratory and Related Diseases $458,179
93.103 Food and Drug Administration Research: General Grant Funding $300,000